Literature DB >> 17439029

Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature.

Paolo Aurello1, Francesco D'Angelo, Simone Rossi, Riccardo Bellagamba, Claudia Cicchini, Giuseppe Nigri, Giorgio Ercolani, Renato De Angelis, Giovanni Ramacciato.   

Abstract

The tumor, node, metastasis (TNM) system has become the principal method for assessing the extent of disease, determining prognosis in gastric cancer patients, and affecting the therapy strategies. The extent of lymph node metastasis is the most important prognostic factor. The aim of this study was to compare the N-classifications of the 4th and the 5th-6th TNM editions and to evaluate retrospectively the prognostic value of the 2002 TNM edition. We evaluated 344 patients who underwent curative total or subtotal gastrectomy. Nodal involvement was detected in 221 (64%) patients. Median follow-up period was 76 months. Thirty per cent of the old N1 patients were reclassified as pN2 (18.5%) and pN3 (11.3%). Eighty-eight per cent of the old N2 patients were reclassified as pN1 (75%) and pN3 (13.7%). In reclassifying the patients, statistically significant changes were reported between 1987 and 2002 TNM stage grouping, mainly in stage IIIB and IV. The 5-year survival rate per stage group did not statistically differ between the 4th and the 5th-6th editions, although a diminutive trend was registered in the IIIA stage. pTNM stage, nodal numerical stage, nodal topographical stage, and depth of tumor invasion resulted in significantly independent prognostic factors. Our data confirm the simplicity and easy application of the new stadiation and the better prognostic stratification of the N-stage. The pN3 group showed a worse prognosis independent of location. On the other hand, prognostic value of pN1 and pN2 stage is lower, probably depending on lymph node location. In multivariate analysis, the difference between old and new TNM staging is low. Hence, we suggest comparing lymph node location and number in larger series. In our series, in pT1 tumors, neither pN2 nor pN3 involvement was found. Hence, in our opinion, for correct N-staging, 10 lymph nodes in early gastric cancer and at least 16 in the other pT-stages seem sufficient for a real pN0 stadiation.

Entities:  

Mesh:

Year:  2007        PMID: 17439029

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  35 in total

1.  Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer.

Authors:  Long-Bin Xiao; Jian-Xing Yu; Wen-Hui Wu; Feng-Feng Xu; Shi-Bin Yang
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

2.  Outcome of photodynamic therapy for early esophageal cancer.

Authors:  Young Koog Cheon; Wan Jung Kim; Joo Young Cho; Joon Seong Lee; Moon Sung Lee; Chan Sup Shim
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

Review 3.  Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies.

Authors:  Jizhun Zhang; Yangbing Zhou; Kewei Jiang; Zhanlong Shen; Yingjiang Ye; Shan Wang
Journal:  Tumour Biol       Date:  2014-04-03

4.  Improving the AJCC/TNM classification for use in early gastric cancer.

Authors:  Paolo G Gobbi; Lara Villano; Donatella Pozzoli; Manuela Bergonzi; Alessandro Vanoli; Francesca Tava; Paolo Dionigi; Gino Roberto Corazza
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

5.  Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India.

Authors:  Sajjad Karim; Arif Ali
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

6.  Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers.

Authors:  Kangkang Zhi; Xiaojun Shen; Hao Zhang; Jianwei Bi
Journal:  J Exp Clin Cancer Res       Date:  2010-06-08

7.  Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival.

Authors:  Loris Bertazza; Simone Mocellin; Alberto Marchet; Pierluigi Pilati; Joseph Gabrieli; Romano Scalerta; Donato Nitti
Journal:  J Transl Med       Date:  2009-12-22       Impact factor: 5.531

Review 8.  Clinical significance of lymph node metastasis in gastric cancer.

Authors:  Jing-Yu Deng; Han Liang
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

9.  The effect of adjuvant chemotherapy on stage IV (T4N1-3M0 and T1-3N3M0) gastric cancer.

Authors:  Tae Kyung Ha; Min Sung Jung; Kang Hong Lee; Kyeong Geun Lee; Sung Joon Kwon
Journal:  Cancer Res Treat       Date:  2009-03-31       Impact factor: 4.679

10.  Gastric cancer: predictors of recurrence when lymph-node dissection is inadequate.

Authors:  Esther Uña
Journal:  World J Surg Oncol       Date:  2009-09-17       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.